ArticleLiver cancer2024

Challenges in Adjuvant Immunotherapy after Resection or Ablation for Hepatocellular Carcinoma at High-Risk of Recurrence.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.